Emeis: Olivier Dussopt Set to Succeed Guillaume Pepy as Board Chairman
On April 7, 2026, the board of directors of Emeis decided to propose Olivier Dussopt as the new chairman of the board and director, replacing Guillaume Pepy, to the general assembly's vote. Laurent Guillot's mandate as CEO will also be proposed for renewal.
Olivier Dussopt, a parliamentarian and mayor of Annonay, has been nominated to serve as the director and chairman of the board of Emeis, replacing Guillaume Pepy. Having served as a minister from 2017 to 2024 (Public Service, Public Accounts, Labor under Elisabeth Borne), Dussopt has been a consultant since 2024. He also holds board positions at La Poste Group, CDC Habitat, and COMET. Laurent Guillot is also proposed for the renewal of his term as CEO. These nominations are subject to the approval of the general assembly scheduled for June 23, 2026, and will take effect following the meeting for a term of four years.
Board Renewals Proposed
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
Almost there! Check your inbox.
A confirmation email has been sent. Click the link to confirm your subscription.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
The board of directors also proposed the renewal of the mandates of Audrey Girard, representative of the Caisse des Dépôts, Stéphane Dessirier, representative of MACSF Epargne Retraite, and Frédérique Mozziconacci, nominated by MAIF. Guillaume Pepy, who has been the chairman since July 2022, chose not to renew his mandate in order to pursue other professional projects.
SectorSanté · Etablissements de santé / EHPAD›Etablissements de santé
Context
Period
Period: 9M 2025
Guidance from the release
Croissance organique soutenue (+6,4% à fin septembre 2025, +7,0% au T3), amélioration notable des taux d'occupation, objectifs de cessions dépassés (2,1 Md€) et confirmation des perspectives 2025 et de la trajectoire 2024-2028.
Risks mentioned
Risques et incertitudes liés aux conditions de marché futures pouvant affecter les résultats prévisionnels
Risque de non-réalisation ou de délai des cessions actuellement sécurisées ou en négociation
Impact transitoire des ouvertures récentes sur les taux d'occupation dans certaines zones
Opportunities identified
Croissance démographique des plus de 75 ans (+30% d'ici 10 ans) créant une demande structurelle accrue
Déficit structurel d'offre (déficit attendu de lits sur principaux marchés) offrant une forte visibilité commerciale
Possibilités de capture d'effets prix favorables et d'amélioration de marges opérationnelles
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
